Safety of an alkalinizing buffer designed for inhaled medications in humans

Keyphrases

• Inhalation 100%
• Inhaled Medications 100%
• Glycine 85%
• Airway 42%
• Vital Signs 42%
• Healthy Controls 42%
• Obstructive Airway Disease 42%
• High Dose 28%
• Safety Study 28%
• No Adverse Effect 28%
• Alkalinization 28%
• Exhaled Breath Condensate pH 28%
• Pulmonary Function 14%
• Phase II Study 14%
• Lung Function 14%
• Adverse Events 14%
• Spirometry 14%
• Clinical Safety 14%
• Surrogate Marker 14%
• Non-smoking 14%
• Fractional Exhaled Nitric Oxide (FeNO) 14%
• Nebulized Hypertonic Saline 14%
• PH Modifier 14%
• Airway Acidification 14%
• Spirometric Parameters 14%
• Airway pH 14%

Medicine and Dentistry

• Drug Therapy 100%
• Buffer 100%
• Exhalation 85%
• Adverse Event 42%
• Vital Sign 42%
• Obstructive Airway Disease 42%
• Drug Megadose 28%
• Exhaled Breath Condensate 28%
• Disease 14%
• Nitric Oxide 14%
• Low Drug Dose 14%
• Lung Function 14%
• Spirometry 14%
• Disease Marker 14%
• Lung 14%
• Table Salt 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Buffer 100%
• Adverse Event 42%
• Obstructive Airway Disease 42%
• Disease 14%
• Normal Human 14%
• Nitric Oxide 14%
• Disease Marker 14%
• Table Salt 14%